Leslie Naesens

Leslie Naesens

Auto-generated profile, based on publicly available information

Leslie Naesens

Ghent University Hospital 1 Department of Internal Medicine Ghent

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
LHLevi Hoste
Levi Hoste
LRLisa Roels
Lisa Roels
LNLeslie Naesens
Leslie Naesens
VBVictor Bosteels
Victor Bosteels
SVStijn Vanhee
Stijn Vanhee
STSimon J. Tavernier
Simon J. Tavernier
In rare instances, pediatric SARS-CoV-2 infection results in a novel immunodysregulation syndrome termed multisystem inflammatory syndrome in children (MIS-C). We compared MIS-C immunopathology with severe COVID-19 in adults. MIS-C does not result in pneumocyte damage but is associated with vascular endotheliitis and gastrointestinal epithelial injury. In MIS-C, the cytokine release syndrome is characterized by IFNγ and not type I interferon. Persistence of patrolling monocytes differentiates MIS-C from severe COVID-19, which is dominated by HLA-DRlo classical monocytes. IFNγ levels correlate with granzyme B production in CD16+ NK cells and TIM3 expression on CD38+/HLA-DR+ T cells. Single-cell TCR profiling reveals a skewed TCRβ repertoire enriched for TRBV11-2 and a superantigenic signature in TIM3+/CD38+/HLA-DR+ T cells. Using NicheNet, we confirm IFNγ as a central cytokine in the communication between TIM3+/CD38+/HLA-DR+ T cells, CD16+ NK cells, and patrolling monocytes. Normalization of IFNγ, loss of TIM3, quiescence of CD16+ NK cells, and contraction of patrolling monocytes upon clinical resolution highlight their potential role in MIS-C immunopathogenesis.

3 July 2015 in European Radiology
Verified
Journal Article
Closed access
PDF file
Pieter Julien Luc De VisscherePieter Julien Luc De Visschere
Pieter Julien Luc De Visschere
LNLeslie Naesens
Leslie Naesens
LLLouis Libbrecht
Louis Libbrecht
CPCharles Van Praet
Charles Van Praet
NLNicolaas Lumen
Nicolaas Lumen
GVGeert Villeirs
Geert Villeirs

21 October 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
STS. J. Tavernier
S. J. Tavernier
VAV. Athanasopoulos
V. Athanasopoulos
PVP. Verloo
P. Verloo
GBG. Behrens
G. Behrens
Jens StaalJens Staal
Jens Staal
FHF. Haerynck
F. Haerynck
Hyperinflammatory syndromes are life-threatening disorders caused by overzealous immune cell activation and cytokine release, often resulting from defects in negative feedback mechanisms. In the quintessential hyperinflammatory syndrome familial hemophagocytic lymphohistiocytosis (HLH), inborn errors of cytotoxicity result in effector cell accumulation, immune dysregulation and, if untreated, tissue damage and death. Here, we describe a human case with a homozygous nonsense R688*RC3H1mutation suffering from hyperinflammation, presenting as relapsing HLH.RC3H1encodes Roquin-1, a posttranscriptional repressor of immune-regulatory proteins such as ICOS, OX40 and TNF. Comparing the R688* variant with the murine M199R variant reveals a phenotypic resemblance, both in immune cell activation, hypercytokinemia and disease development. Mechanistically, R688* Roquin-1 fails to localize to P-bodies and interact with the CCR4-NOT deadenylation complex, impeding mRNA decay and dysregulating cytokine production. The results from this unique case suggest that impaired Roquin-1 function provokes hyperinflammation by a failure to quench immune activation.

25 November 2022 in Science Immunology
Verified
Journal Article
Closed access
LNLeslie Naesens
Leslie Naesens
SMSantoshi Muppala
Santoshi Muppala
DADhiraj Acharya
Dhiraj Acharya
JNJosephine Nemegeer
Josephine Nemegeer
DBDelfien Bogaert
Delfien Bogaert
FHFilomeen Haerynck
Filomeen Haerynck
Herpes simplex virus 1 (HSV-1) infects several billion people worldwide and can cause life-threatening herpes simplex encephalitis (HSE) in some patients. Monogenic defects in components of the type I interferon system have been identified in patients with HSE, emphasizing the role of inborn errors of immunity underlying HSE pathogenesis. Here, we identify compound heterozygous loss-of-function mutations in the gene GTF3A encoding for transcription factor IIIA (TFIIIA), a component of the RNA polymerase III complex, in a patient with common variable immunodeficiency and HSE. Patient fibroblasts and GTF3A gene–edited cells displayed impaired HSV-1–induced innate immune responses and enhanced HSV-1 replication. Chromatin immunoprecipitation sequencing analysis identified the 5 S ribosomal RNA pseudogene 141 ( RNA5SP141 ), an endogenous ligand of the RNA sensor RIG-I, as a transcriptional target of TFIIIA. GTF3A mutant cells exhibited diminished RNA5SP141 expression and abrogated RIG-I activation upon HSV-1 infection. Our work unveils a crucial role for TFIIIA in transcriptional regulation of a cellular RIG-I agonist and shows that GTF3A genetic defects lead to impaired cell-intrinsic anti–HSV-1 responses and can predispose to HSE.

11 November 2019 in British Journal of Haematology
Verified
Journal Article
Closed access
PDF file
DBDelfien Joke Ann Bogaert
Delfien Joke Ann Bogaert
GLGenevieve Laureys
Genevieve Laureys
LNLeslie Naesens
Leslie Naesens
DMDominiek Mazure
Dominiek Mazure
MBMarieke De Bruyne
Marieke De Bruyne
TKTessa Kerre
Tessa Kerre

1 February 2021 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
LNLeslie Naesens
Leslie Naesens
JSJulie Smet
Julie Smet
STSimon J. Tavernier
Simon J. Tavernier
PSPetra Schelstraete
Petra Schelstraete
LHLevi Hoste
Levi Hoste
FHFilomeen Haerynck
Filomeen Haerynck